S 5682
Alternative Names: Alnenor; Alvenor; Ardium; Arvenum; Capivan; Capiven; Daflon; Detralex; Variton; VenitolLatest Information Update: 17 Dec 2021
Price :
$50 *
At a glance
- Originator Servier
- Class Antihistamines; Flavanones; Flavones
- Mechanism of Action Antioxidants; Prostaglandin synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Haemorrhoids; Venous insufficiency
Most Recent Events
- 10 Oct 2019 Servier completes a phase III trial for Venous-insufficiency in Hungary and Austria (EudraCT2017-003633-28)
- 02 May 2018 Servier initiates enrolment in a phase III trial for Venous-insufficiency in Hungary (EudraCT2017-003633-28)
- 05 Nov 2003 Launched for Haemorrhoids in Belgium (PO)